FINANCIAL DISCLOSURE
Bruce Gaynes reports of having no actual or potential conflict of interest in relation to this program.

Ron Melton reports of having no actual or potential conflict of interest in relation to this program.

Randall Thomas reports of having no actual or potential conflict of interest in relation to this program.

ACCREDITATION STATEMENTS
Pharmacists

Jobson is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Program No.: 430-000-06-005-H01
Credits: 2.0 hours (.20 ceu)

Optometrist Accreditation Statement
This course is COPE-qualified for 2 hours of CE credit. Please check with your state licensing board to see if this approval counts towards your actual CE requirements for relicensure.

COPE ID#: 16729-AS

Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696

Direct educational content inquiries to:
CE Director (800) 331-9396

TARGET AUDIENCE
This activity has been designed to meet the educational needs of pharmacists, pharmacy technicians, and optometrists. Estimated time to complete this monograph and posttest is 90 to 120 minutes.

PROCEDURES
To receive credit and your exam score, please complete the exam questions and program evaluation.

GOAL
To provide pharmacists and optometrists with an increased awareness of the diagnosis and management of dry eye syndrome.

EDUCATIONAL OBJECTIVES
At the conclusion of this program, participants will be able to:

1. Review the signs, symptoms, and diagnosis of dry eye syndrome;
2. Describe the underlying factors that may cause dry eye syndrome, including comorbidities;
3. Discuss the current and newer treatment approaches towards patients with dry eye syndrome; and
4. List strategies for pharmacists to identify patients with dry eye syndrome and to make appropriate treatment recommendations.

Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Power-Pak C.E. and Alimera Sciences.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.